Data / Form D filings / SNC Therapeutics, Inc.
SNC Therapeutics, Inc.: Form D filing
SNC Therapeutics, Inc., a biotechnology company in Evanston, IL, filed a Form D with the SEC in 2023. The latest, on March 8, 2023, reports $249,999 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1801 Maple Avenue, Querrey InQbation Lab, Suite 1400, Evanston, IL, 60201
- Phone
- (904) 707-9016
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966964
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | New notice | $4,999,999 | $249,999 | $4,750,000 | 1 | Feb 22, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Margarita A. Chavez | Director | |
| Evan A. Scott | Executive Officer, Director | |
| Jeffrey A. Hubbell | Executive Officer |
Other biotechnology companies in Illinois that filed recently
- Neopenda, PBC $215,000 · Aug 27, 2026
- Auvi Labs, Inc. $442,352 · Aug 26, 2026
- Archean Sciences, Inc. $385,000 · Aug 13, 2026
Every Form D from the week of Mar 6, 2023 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SNC Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.